Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PROCEPT BioRobotics Corporation - Common Stock
(NQ:
PRCT
)
35.66
-0.44 (-1.22%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
996,130
Open
36.17
Bid (Size)
35.79 (300)
Ask (Size)
37.10 (400)
Prev. Close
36.10
Today's Range
34.58 - 36.20
52wk Range
27.80 - 92.92
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Underrated Robotics Stocks Poised for Huge Gains
↗
December 15, 2025
Via
MarketBeat
PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
November 20, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Performance
YTD
-57.1%
-57.1%
1 Month
+22.6%
+22.6%
3 Month
-9.9%
-9.9%
6 Month
-39.6%
-39.6%
1 Year
-60.1%
-60.1%
More News
Read More
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
November 04, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Where PROCEPT BioRobotics Stands With Analysts
↗
April 25, 2025
Via
Benzinga
Earnings Scheduled For April 24, 2025
↗
April 24, 2025
Via
Benzinga
2 Robotics Stocks Riding the Sensor and Medical Boom
↗
October 29, 2025
Via
The Motley Fool
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?
↗
October 24, 2025
Via
The Motley Fool
Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock
↗
October 15, 2025
Via
Benzinga
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
October 15, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts
↗
September 02, 2025
Via
Benzinga
Procept (PRCT) Q2 Revenue Jumps 48%
↗
August 06, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
PROCEPT BioRobotics (PRCT) Earnings Transcript
↗
August 06, 2025
Via
The Motley Fool
Topics
World Trade
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline
↗
August 06, 2025
Via
Chartmill
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
August 06, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Uncovering Potential: PROCEPT BioRobotics's Earnings Preview
↗
August 05, 2025
Via
Benzinga
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
July 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
July 23, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
July 21, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
July 14, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
April 29, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
April 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
April 24, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
April 10, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Frequently Asked Questions
Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?
Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
The current price of PROCEPT BioRobotics Corporation - Common Stock is 35.66
When was PROCEPT BioRobotics Corporation - Common Stock last traded?
The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 12/16/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today